Cms formulary id: «cms_formulary_id»

Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013

DRUG NAME
DILANTIN 50 MG ORAL

CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC

REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW
GENERIC EQUIVALENT.

OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013

DRUG NAME
DUETACT 30 MG-2 MG ORAL

CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC

REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW
GENERIC EQUIVALENT.

OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013

DRUG NAME
DUETACT 30 MG-4 MG ORAL

CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC

REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW
GENERIC EQUIVALENT.

OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013

DRUG NAME
GRIS-PEG 250 MG ORAL

CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC

REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW
GENERIC EQUIVALENT.

OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013

DRUG NAME
PROTONIX IV 40 MG INTRAVEN.

CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC

REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW
GENERIC EQUIVALENT.

OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013

DRUG NAME
TRICOR 145MG ORAL

CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC

REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW
GENERIC EQUIVALENT.

OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013

DRUG NAME
TRICOR 48 MG ORAL

CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC

REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW
GENERIC EQUIVALENT.

OTHER POSSIBLE DRUGS
Alliance CompleteCare
Future Formulary Change File
CMS FORMULARY ID: 13348
EFFECTIVE DATE: 6/1/2013

DRUG NAME
ZERIT 1 MG/ML ORAL

CHANGE DESCRIPTION
BRAND DELETION, ADD FRF GENERIC

REASON DESCRIPTION
REMOVAL OF BRAND NAME DRUG FROM FORMULARY DUE TO ADDITION OF NEW
GENERIC EQUIVALENT.

OTHER POSSIBLE DRUGS

Source: https://www.alamedaalliance.org/~/media/files/modules/publications/pharmacy/2013%20acc%20pharmacy%20documents/future%20formulary%20change_june%202013.pdf

Abstracts of the 9th world congress of biological psychiatry

Abstracts of the 9th World Congress of Biological Psychiatry PSyChOTiC diSOrderS - Poster Presentations methods: 39 patients (17 female, 12 male, average age 24,8 years) di- p-06-018 agnosed initials with FE and after one year with schizophrenia according parametric variation in working memory demand in patients with DSM-IV criteria were five years of psychiatric (PANSS,CGI-S, CGI-

Trs080214

BEFORE THE ALASKA OFFICE OF ADMINISTRATIVE HEARINGS ON REFERRAL FROM THE DEPARTMENT OF ADMINISTRATION ORDER GRANTING SUMMARY ADJUDICATION S E is a retiree under the Teachers’ Retirement System (“TRS”) and is entitled to benefits of the AlaskaCare Retiree Health Plan (“Plan”). On September 26, 2007, Mr. E underwent radical retropubic prostatectomy surgery at the Mayo Clinic.

© 2008-2018 Medical News